Bristol-Myers Squibb and Denmark’s Nordic Bioscience inked a deal to develop biomarker technology to diagnose and monitor nonalcoholic steatohepatitis.

Abbott and Alere agreed on a new price of $5.3 billion for their deal and to dismiss their respective lawsuits.

ALung Technologies raised $36 million to trial its artificial lung technology for patients with respiratory failure.

Johnson & Johnson unit Codman Neuro has picked up privately held Galway, Ireland-based stroke care company Neuravi for an undisclosed price, giving J&J…

ArcherDX and HeliTec are teaming up to develop NGS-based cancer diagnostics in China.

Cancer Genetics has tapped Mendel Health for help matching patients to oncology clinical trials.

B. Braun and Philips have teamed up to work on ultrasound-guided regional anesthesia products.

Philips is partnering with PathAI to improve the speed and accuracy of cancer diagnosis.

Boston Scientific will pony up $435 million upfront to acquire Switzerland’s Symetis, which makes TAVI devices.